FDA approves Revlimid as maintenance therapy in multiple myeloma after autologous HSCT Feb. 23, 2017 No Comments
Truxima becomes the first biosimilar MAb in oncology to be granted E.U. marketing authorization Feb. 23, 2017 No Comments
FDA grants accelerated approval to Opdivo in metastatic urothelial carcinoma Feb. 3, 2017 No Comments
European Commission approves Votubia to treat refractory partial-onset seizures associated with TSC Jan. 31, 2017 No Comments
RSS